"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant epithelial tumor with a glandular organization.
| Descriptor ID |
D000230
|
| MeSH Number(s) |
C04.557.470.200.025
|
| Concept/Terms |
Adenocarcinoma- Adenocarcinoma
- Adenocarcinomas
- Adenoma, Malignant
- Adenomas, Malignant
- Malignant Adenoma
- Malignant Adenomas
Carcinoma, Granular Cell- Carcinoma, Granular Cell
- Carcinomas, Granular Cell
- Granular Cell Carcinoma
- Granular Cell Carcinomas
- Adenocarcinoma, Granular Cell
- Adenocarcinomas, Granular Cell
- Granular Cell Adenocarcinoma
- Granular Cell Adenocarcinomas
Adenocarcinoma, Tubular- Adenocarcinoma, Tubular
- Adenocarcinomas, Tubular
- Tubular Adenocarcinoma
- Tubular Adenocarcinomas
- Carcinoma, Tubular
- Carcinomas, Tubular
- Tubular Carcinoma
- Tubular Carcinomas
Carcinoma, Cribriform- Carcinoma, Cribriform
- Carcinomas, Cribriform
- Cribriform Carcinoma
- Cribriform Carcinomas
Adenocarcinoma, Basal Cell- Adenocarcinoma, Basal Cell
- Adenocarcinomas, Basal Cell
- Basal Cell Adenocarcinoma
- Basal Cell Adenocarcinomas
Adenocarcinoma, Oxyphilic- Adenocarcinoma, Oxyphilic
- Adenocarcinomas, Oxyphilic
- Oxyphilic Adenocarcinoma
- Oxyphilic Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma".
- Adenocarcinoma
- Adenocarcinoma in Situ
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenocarcinoma, Mucinous
- Adenocarcinoma, Papillary
- Adenocarcinoma, Scirrhous
- Adenocarcinoma, Sebaceous
- Adrenocortical Carcinoma
- Carcinoid Tumor
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Skin Appendage
- Cholangiocarcinoma
- Choriocarcinoma
- Cystadenocarcinoma
- Eccrine Porocarcinoma
- Paget Disease, Extramammary
- Pulmonary Adenomatosis, Ovine
This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 13 | 6 | 19 |
| 1996 | 8 | 4 | 12 |
| 1997 | 12 | 2 | 14 |
| 1998 | 10 | 6 | 16 |
| 1999 | 11 | 3 | 14 |
| 2000 | 11 | 5 | 16 |
| 2001 | 11 | 3 | 14 |
| 2002 | 7 | 0 | 7 |
| 2003 | 18 | 2 | 20 |
| 2004 | 8 | 4 | 12 |
| 2005 | 15 | 3 | 18 |
| 2006 | 13 | 3 | 16 |
| 2007 | 15 | 4 | 19 |
| 2008 | 19 | 6 | 25 |
| 2009 | 29 | 7 | 36 |
| 2010 | 19 | 6 | 25 |
| 2011 | 12 | 9 | 21 |
| 2012 | 23 | 6 | 29 |
| 2013 | 29 | 11 | 40 |
| 2014 | 28 | 4 | 32 |
| 2015 | 32 | 1 | 33 |
| 2016 | 20 | 8 | 28 |
| 2017 | 26 | 5 | 31 |
| 2018 | 37 | 8 | 45 |
| 2019 | 24 | 1 | 25 |
| 2020 | 16 | 3 | 19 |
| 2021 | 14 | 2 | 16 |
| 2022 | 20 | 1 | 21 |
| 2023 | 15 | 0 | 15 |
| 2024 | 11 | 1 | 12 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clin Cancer Res. 2025 Feb 03; 31(3):551-560.
-
The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging. Prostate. 2025 Apr; 85(5):413-423.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication. JAMA Surg. 2024 Dec 01; 159(12):1365-1373.
-
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Lett. 2025 Feb 01; 610:217354.
-
Irreversible electroporation for prostate cancer: another promising focal therapy. Einstein (Sao Paulo). 2024; 22:eRC0779.
-
Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial. Lancet Gastroenterol Hepatol. 2025 Jan; 10(1):34-43.
-
Comparative Outcomes and Toxicity in Patients With Esophageal Cancer After Trimodality Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy: The MD Anderson Experience. Clin Oncol (R Coll Radiol). 2025 Feb; 38:103668.
-
HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival. Eur J Surg Oncol. 2025 Jan; 51(1):108790.
-
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish. J Clin Oncol. 2025 Jan 20; 43(3):339-349.